produced  by  microorganisms  such  as  G. vaginalis, 
M. hominis,  and  Mobiluncus spp,  which  is 
overgrowth in BV. Semen which is alkaline (pH 7.2) 
lead to the release of amin from its attachment with 
the  protein  amine  and  producing  a  typical  odor 
(Karim, 2016) (Bradshaw et al., 2013).  
The  use  of  vaginal  douching  is  a  risk  factor  for 
BV  occurence  in  some  women.  This  study  found 
that  60%  BV  patients  frequently  used  vaginal 
douching. Washing the vagina (douching) associated 
with  complaints  of  dysuria,  vaginal  discharge,  and 
itching of the vagina. Vaginal douching, reported to 
cause  changes  in  vaginal  pH  and  reduces  the 
concentration  of  normal  microbiota,  facilitating  the 
growth  of  opportunistic  pathogenic  bacteria.  The 
cessation  of  this  habit  may  reduce  the  risk  of  BV 
(Brotman et al., 2008).  
Most  patients  with  BV  in  this  study  were 
classified  overweight  and  obesity.  Ventolini  et  al 
showed  that  obesity  increases  the  risk  of  BV  by  4 
fold.  Obesity  is  a  mild  inflammatory  condition, 
which  affect  the  mechanisms  of  immunity  in  the 
vagina. Obesity is an independent risk factor of BV 
(Ventolini et al., 2017). 
IUD is  a contraceptive  method  that widely  used 
in  patients  with  BV.  Previous  study  showed  that 
IUD users had 1.84 times increased risk of BV. The 
IUD can alter the normal vaginal flora, and promote 
the  growth  of  pathogenic  bacteria  (Joesof  et  al., 
2001)  (Oduyebo,  Anorlu  and  Ogunsola,  2009). 
Analysis  on  our  study  showed  contrary  result,  that 
IUD was not significantly increases the risk of BV.  
Most symptoms that emerged in this study was 
excessive  vaginal  discharge,  vaginal  odor  and 
itching.  These  are  in  line  with  previous  study 
conducted  by  Abdul  Karim  and  Jusuf  Barakbah  in 
Dermatology  Outpatient  Clinic  Dr.  Soetomo 
Hospital,  where  33.3%  of  patients  experiencing 
vaginal odor and 28.6% complained vaginal itching. 
Association  between  accompanying  complain  and  
BV in this study were not significant (p>0.05).  
In  term  of  response  to  BV  therapy,  78.4% 
showed good result and improved condition, as seen 
by  negative  BV  examination.  Treatment  evaluation 
was performed using vaginal swab then assessed by 
Nugent  score.  Metronidazole  and  Clindamycin  are 
used  as  the  first  line  therapy  in  this  study,  as 
recommended  by  CDC  in  2014  (Oduyebo,  Anorlu 
and  Ogunsola,  2009)  (Hoffman  et  al.,  2016). 
Metronidazole  inhibit  anaerobes  that  support 
Gardnerella vaginalis but do not affect Lactobacilli 
spp., thereby reducing the risk of late-stage relapse. 
Clindamycin  is  effective  alternative  drug.  All  these 
antibiotics have been shown to achieve cure rates of 
70%  to  80%  after  treatment  (Oduyebo,  Anorlu  and 
Ogunsola,  2009).  The  reccurance  rate  of  BV  after 
successfull therapy show variety result, starting from 
< 3 month until > 1 years, and fortunately 36.4% of 
patients never experienced relapse This study did not 
found  any  significant  association  between  all  risk
 
factors and BV.
  
5  CONCLUSIONS 
In  this  study,  it  was  concluded  that  the 
characteristics  of  the  patients  who  come  to  the 
Gynecology Outpatient Clinic Dr Soetomo Hospital 
complaining  excessive  vaginal  discharge  are  on 
productive  age.  Most  patients  diagnosed  using 
vaginal  swab  and  Nugent  score.  The  treatment  of 
BV  using  standard  regimen  such  as  Metronidazole 
and  Clindamycin  still  proven  to  be  effective,  and 
able  to  prevent  some  relapse.Unfortunately  in  this 
study we could not found any significant association 
between all risk factors and BV.  
ACKNOWLEDGEMENTS 
The  authors  wish  to  thank  all  Resident  Obstetric 
Gynecolgy  and  staff  in  Gynecology  Outpatient 
Clinic  Dr  Soetomo  Hospital  for  their  dedication  in 
collecting  data,  and  all  the  women  whose 
participation contributed to the success of this study. 
REFERENCES 
Bilardi J, Walker S, Mooney-Somers J, Temple-Smith M, 
McNair  R,  Bellhouse  C,  et  al.  2016.  Women’s  views 
and  experiences  of  the  triggers  for  onset  of  bacterial 
vaginosis  and  exacerbating  factors  associated  with 
recurrence.  PLoS One  [Internet].  11(3):1–15. 
Available  from: 
http://dx.doi.org/10.1371/journal.pone.0150272  
Bradshaw CS, Vodstrcil LA, Hocking JS, Law M, Pirotta 
M,  Garland  SM,  et  al.  2013.  Recurrence  of  bacterial 
vaginosis is significantly associated with posttreatment 
sexual activities and hormonal contraceptive use. Clin 
Infect Dis, 56(6):777–86.  
Brotman  RM,  Ghanem  KG,  Klebanoff  MA,  Taha  TE, 
Scharfstein  DO,  Zenilman  JM.  2008.  The  effect  of 
vaginal  douching  cessation  on  bacterial  vaginosis:  a 
pilot study. Am J Obstet Gynecol, 198(6).  
Hoffman BL, Schorge JO, Bradshaw KD, Halvorson LM, 
Schaffer JI, Corton MM. 2016. Gynecologic Infection. 
In:  Williams  Gynecology.  3rd  ed.  New York: 
McGraw-Hill Education LLC; p. 50–2.